Skip to main content

Table 3 Clinical and biological characteristics associated with incidence of major amputation

From: Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes

Variables

HR (95% CI)

p value

Male gender

5.29 (2.38–11.75)

< 0.0001

Age (years)

1.03 (1.00–1.06)

0.031

BMI (kg/m2)

0.97 (0.92–1.01)

0.185

Active smoking

1.82 (0.91–3.63)

0.089

Heart rate (bpm)

0.99 (0.97–1.01)

0.643

SBP (mmHg)

1.03 (1.01–1.04)

0.0001

DBP (mmHg)

1.00 (0.98–1.03)

0.596

Diabetes duration (per year)

1.03 (1.01–1.06)

0.014

LDL-cholesterol (mmol/l)

1.24 (0.60–2.57)

0.554

HbA1c (%)

0.88 (0.72–1.07)

0.217

eGFR, ml min−1 (1.73 m)−2

0.97 (0.96–0.98)

< 0.0001

Microangiopathy components

 uACR (reference < 3 mg/mmol)a

 

< 0.0001

 3–30 mg/mmol

2.12 (0.91–4.89)

 

 > 30 mg/mmol

6.64 (3.11–14.20)

 

Severe diabetic retinopathy

2.51 (1.35–4.64)

0.003

Macular edema

2.13 (1.07–4.25)

0.032

Macroangiopathy components

 Ischemic heart disease

1.14 (0.62–2.12)

0.667

 Carotid artery disease

1.15 (0.54–2.45)

0.715

 Peripheral artery disease

12.05 (6.87–21.12)

< 0.0001

Biological markers

 TNFR1α (per 10 log pg/ml)

1.37 (1.26–1.48)

<0.0001

 ANGPTL2 (per 10 log ng/ml)

1.33 (1.20–1.48)

< 0.0001

  1. Data presented here are univariate Cox proportional hazard model. Italic data indicate p values below the statistical significance threshold
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, uACR urinary albumin-to-creatinine ratio
  3. aMissing data at baseline for 149 patients